Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden.

Background: Little is known about the characteristics of individuals with irritable bowel syndrome (IBS) according to stool subtype or the most troublesome symptom reported by the individual, or whether these are useful in predicting the impact of IBS. Method s : We collected demographic, gastrointestinal, and psychological symptoms, healthcare usage and direct healthcare costs, impact on work and activities of daily living, and quality of life data from individuals with Rome IV‐defined IBS. Key Results: We recruited 752 people with Rome IV IBS. Individuals with IBS‐D reported a poorer disease‐specific quality of life than those with IBS‐C or IBS‐M (mean (SD) IBS‐QOL 45.3 (23.0) for IBS‐D, vs. 52.3 (19.9) for IBS‐C, vs. 49.4 (22.0) for IBS‐M, p = 0.005). Mean (SD) IBS‐QOL scores were also lower amongst those who reported diarrhea (44.8 (22.3)) or urgency (44.6 (22.3)) as their most troublesome symptom, compared with those reporting abdominal pain (52.2 (22.9)), constipation (49.5 (21.8)), or abdominal bloating or distension (50.4 (21.3)). However, there were no differences in mean EQ‐5D scores, IBS severity, levels of anxiety, depression, somatoform symptom‐reporting, or gastrointestinal symptom‐specific anxiety. Direct healthcare costs of IBS were similar across all subtypes and all most troublesome symptom groups, although some differences in work productivity and social leisure activities were detected. Conclusions and Inferences: There appears to be limited variation in the characteristics of individuals with Rome IV IBS based on both stool subtypes and most troublesome symptom reported, suggesting that gastrointestinal symptoms alone have limited ability to predict disease impact and burden. [ABSTRACT FROM AUTHOR]